Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Macrophage-Mediated Phagocytosis and Dissolution of Amyloid-Like Fibrils in Mice, Monitored by Optical Imaging.

Richey T, Foster JS, Williams AD, Williams AB, Stroh A, Macy S, Wooliver C, Heidel RE, Varanasi SK, Ergen EN, Trent DJ, Kania SA, Kennel SJ, Martin EB, Wall JS.

Am J Pathol. 2019 May;189(5):989-998. doi: 10.1016/j.ajpath.2019.01.011. Epub 2019 Feb 6.

PMID:
30735627
2.

Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.

Wall JS, Williams AD, Foster JS, Richey T, Stuckey A, Macy S, Wooliver C, Campagna SR, Tague ED, Farmer AT, Lands RH, Martin EB, Heidel RE, Kennel SJ.

Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10839-E10848. doi: 10.1073/pnas.1805515115. Epub 2018 Oct 30.

3.

Evaluation of the effect of D-amino acid incorporation into amyloid-reactive peptides.

Martin EB, Williams A, Richey T, Wooliver C, Stuckey A, Foster JS, Kennel SJ, Wall JS.

J Transl Med. 2017 Dec 11;15(1):247. doi: 10.1186/s12967-017-1351-0.

4.

A Peptide-Fc Opsonin with Pan-Amyloid Reactivity.

Foster JS, Williams AD, Macy S, Richey T, Stuckey A, Wooliver DC, Koul-Tiwari R, Martin EB, Kennel SJ, Wall JS.

Front Immunol. 2017 Sep 4;8:1082. doi: 10.3389/fimmu.2017.01082. eCollection 2017.

5.

A bifunctional peptide, "peptope", for pre-targeting antibody 7D8 to systemic amyloid deposits.

Wall JS, Williams A, Foster JS, Martin EB, Richey T, Stuckey A, Macy S, Zago W, Kinney GG, Kennel SJ.

Amyloid. 2017 Mar;24(sup1):22-23. doi: 10.1080/13506129.2017.1295372. No abstract available.

6.

Preliminary characterization of a novel peptide-Fc-fusion construct for targeting amyloid deposits.

Foster JS, Koul-Tiwari R, Williams A, Martin EB, Richey T, Stuckey A, Macy S, Kennel SJ, Wall JS.

Amyloid. 2017 Mar;24(sup1):26-27. doi: 10.1080/13506129.2017.1295375. No abstract available.

7.

A novel murine system for validating the specific targeting of peptides to light chain associated (AL) amyloid.

Beierle SP, Foster JS, Richey T, Stuckey A, Macy S, Kennel SJ, Wall JS.

Amyloid. 2017 Mar;24(sup1):74-75. doi: 10.1080/13506129.2017.1295377. No abstract available.

8.

Probing the structural requirements of polybasic peptides for effective and specific amyloid reactivity.

Wall JS, Williams A, Stuckey A, Martin EB, Richey T, Wooliver C, Heidel RE, Cheng X, Kennel SJ.

Amyloid. 2017 Mar;24(sup1):30-31. doi: 10.1080/13506129.2017.1295946. No abstract available.

9.

Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants.

Wall JS, Williams A, Richey T, Stuckey A, Wooliver C, Christopher Scott J, Donnell R, Martin EB, Kennel SJ.

Mol Imaging Biol. 2017 Oct;19(5):714-722. doi: 10.1007/s11307-017-1063-0.

10.

Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.

Martin EB, Williams A, Richey T, Stuckey A, Heidel RE, Kennel SJ, Wall JS.

Sci Rep. 2016 Mar 3;6:22695. doi: 10.1038/srep22695.

11.

The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice.

Kennel SJ, Williams A, Stuckey A, Richey T, Wooliver C, Chazin W, Stern DA, Martin EB, Wall JS.

Amyloid. 2016;23(1):8-16. doi: 10.3109/13506129.2015.1112782. Epub 2015 Dec 24.

12.

Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.

Kennel SJ, Stuckey A, McWilliams-Koeppen HP, Richey T, Wall JS.

Mol Imaging Biol. 2016 Aug;18(4):483-9. doi: 10.1007/s11307-015-0914-9.

13.

Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.

Wall JS, Martin EB, Richey T, Stuckey AC, Macy S, Wooliver C, Williams A, Foster JS, McWilliams-Koeppen P, Uberbacher E, Cheng X, Kennel SJ.

Molecules. 2015 Apr 27;20(5):7657-82. doi: 10.3390/molecules20057657.

14.

Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.

Martin EB, Kennel SJ, Richey T, Wooliver C, Osborne D, Williams A, Stuckey A, Wall JS.

Peptides. 2014 Oct;60:63-70. doi: 10.1016/j.peptides.2014.07.024. Epub 2014 Aug 4.

15.

Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice.

Kennel SJ, Macy S, Wooliver C, Huang Y, Richey T, Heidel E, Wall JS.

Amyloid. 2014 Mar;21(1):45-53. doi: 10.3109/13506129.2013.876400. Epub 2014 Jan 22.

16.

A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivo.

Wall JS, Williams A, Richey T, Stuckey A, Huang Y, Wooliver C, Macy S, Heidel E, Gupta N, Lee A, Rader B, Martin EB, Kennel SJ.

PLoS One. 2013 Jun 4;8(6):e66181. doi: 10.1371/journal.pone.0066181. Print 2013.

17.

A novel method for quantifying peripheral tissue amyloid load by using the radiolabeled amyloidophilic peptide, p5.

Wall JS, Richey T, Macy S, Heidel E, Wooliver C, Kennel SJ.

Amyloid. 2013 Mar;20(1):21-6. doi: 10.3109/13506129.2012.757216. Epub 2013 Jan 17.

18.

AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.

Wall JS, Kennel SJ, Williams A, Richey T, Stuckey A, Huang Y, Macy S, Donnell R, Barbour R, Seubert P, Schenk D.

PLoS One. 2012;7(12):e52686. doi: 10.1371/journal.pone.0052686. Epub 2012 Dec 26.

19.

Characterization of X-ray Dose in Murine Animals Using microCT, a New Low-Dose Detector and nanoDot Dosimeters.

Osborne DR, Yan S, Stuckey A, Pryer L, Richey T, Wall JS.

PLoS One. 2012;7(11):e49936. doi: 10.1371/journal.pone.0049936. Epub 2012 Nov 27.

20.

Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.

Wall JS, Richey T, Williams A, Stuckey A, Osborne D, Martin E, Kennel SJ.

Mol Imaging Biol. 2012 Aug;14(4):402-7. doi: 10.1007/s11307-011-0524-0.

21.

SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.

Wall JS, Richey T, Stuckey A, Donnell R, Oosterhof A, van Kuppevelt TH, Smits NC, Kennel SJ.

Nucl Med Biol. 2012 Jan;39(1):65-75. doi: 10.1016/j.nucmedbio.2011.06.007. Epub 2011 Sep 29.

22.

In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.

Wall JS, Richey T, Stuckey A, Donnell R, Macy S, Martin EB, Williams A, Higuchi K, Kennel SJ.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):E586-94. doi: 10.1073/pnas.1103247108. Epub 2011 Aug 1.

23.

Generation and characterization of anti-AA amyloid-specific monoclonal antibodies.

Wall JS, Kennel SJ, Richey T, Allen A, Stuckey A, Weiss DT, Macy SD, Barbour R, Seubert P, Solomon A, Schenk D.

Front Immunol. 2011 Aug 8;2:32. doi: 10.3389/fimmu.2011.00032. eCollection 2011.

24.

Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice.

Wall JS, Richey T, Allen A, Donnell R, Kennel SJ, Solomon A.

Comp Med. 2008 Dec;58(6):542-50.

25.

Amyloidogenic potential of foie gras.

Solomon A, Richey T, Murphy CL, Weiss DT, Wall JS, Westermark GT, Westermark P.

Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10998-1001. Epub 2007 Jun 19.

26.

Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.

Wall JS, Kennel SJ, Paulus M, Gregor J, Richey T, Avenell J, Yap J, Townsend D, Weiss DT, Solomon A.

J Nucl Med. 2006 Dec;47(12):2016-24.

27.

A deceptive presentation: Addison's disease.

Richey T.

Adv Nurse Pract. 2006 Sep;14(9):57-8. No abstract available.

PMID:
16972446
28.

Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.

Wall JS, Kennel SJ, Paulus MJ, Gleason S, Gregor J, Baba J, Schell M, Richey T, O'Nuallain B, Donnell R, Hawkins PN, Weiss DT, Solomon A.

Amyloid. 2005 Sep;12(3):149-56.

PMID:
16194869
29.

Surface modification of polyethylene balloon catheters for local drug delivery.

Richey T, Iwata H, Oowaki H, Uchida E, Matsuda S, Ikada Y.

Biomaterials. 2000 May;21(10):1057-65.

PMID:
10768758
30.

Yellowish papules on lateral aspect of palms. Focal acral hyperkeratosis.

Richey TK, Fitzpatrick JE.

Arch Dermatol. 1996 Nov;132(11):1365, 1368. No abstract available.

PMID:
8915316
31.

Etiologies of the sicca syndrome: primary systemic amyloidosis and others.

Richey TK, Bennion SD.

Int J Dermatol. 1996 Aug;35(8):553-7.

PMID:
8854150
32.

Persistent cutaneous larva migrans due to Ancylostoma species.

Richey TK, Gentry RH, Fitzpatrick JE, Morgan AM.

South Med J. 1996 Jun;89(6):609-11.

PMID:
8638201
33.

Surgery of the thyroid gland: a 10-year-experience.

Richey TH, Kurzweg FT, McDonald JC.

J La State Med Soc. 1978 Mar;130(3):65-7. No abstract available.

PMID:
641382
34.

Effects of gamma radiation on development of Brugia pahangi in a susceptible strain of Aedes aegypti.

Richey TJ, Rodriguez PH.

J Parasitol. 1976 Aug;62(4):655-6. No abstract available.

PMID:
957050
35.

Routine vaginal examinations during labor: comparative study with bacteriologic analysis.

PETERSON WF, RICHEY TW.

Ill Med J. 1962 Jul;122:35-8. No abstract available.

PMID:
14485815
36.

Headlight.

BERSON WL, RICHEY TV.

Anesthesiology. 1959 Nov-Dec;20:889-90. No abstract available.

PMID:
13799925
37.

Experiences with the Kolff twin coil artificial kidney.

HOLMES JH, STONINGTON OG, VAN SCHOONHOVEN P, RICHEY TW, TAKEDA Y.

J Urol. 1958 Aug;80(2):102-9. No abstract available.

PMID:
13564596
38.

Diffuse traumatic degeneration of the cerebral gray matter.

DENST J, RICHEY TW, NEUBUERGER KT.

J Neuropathol Exp Neurol. 1958 Jul;17(3):450-60. No abstract available.

PMID:
13564256
39.

[Experiences with the Kolff twin coil artificial kidney].

HOLMES JH, STONINGTON OG, VAN SCHOONHOVEN P, RICHEY TW, TAKEDA Y.

Trans South Cent Sect Am Urol Assoc. 1957;52:1-9. Undetermined Language. No abstract available.

PMID:
13556877

Supplemental Content

Loading ...
Support Center